VRNA
Verona Pharma
VRNA
VRNA
Delisted
VRNA was delisted on the 6th of October, 2025.
95 hedge funds and large institutions have $1.22B invested in Verona Pharma in 2023 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 39 increasing their positions, 21 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.3% more ownership
Funds ownership: 9.26% → 9.56% (+0.3%)
7% less capital invested
Capital invested by funds: $1.31B → $1.22B (-$90.4M)
13% less funds holding in top 10
Funds holding in top 10: 16 → 14 (-2)
Holders
95
Holding in Top 10
14
Calls
$3.52M
Puts
$2.14M
Top Buyers
| 1 | +$49.3M | |
| 2 | +$48.1M | |
| 3 | +$30M | |
| 4 |
PBA
Paradigm Biocapital Advisors
New York
|
+$19.3M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$18.9M |
Top Sellers
| 1 | -$43.1M | |
| 2 | -$6.34M | |
| 3 | -$6.32M | |
| 4 |
O
OrbiMed
New York
|
-$6.26M |
| 5 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$5.83M |